Skip to main content

ADVERTISEMENT

Winston Wong, PharmD, Editor-in-Chief

Editor's Page
11/19/2018
Winston Wong, PharmD, Editor-in-Chief
The internet has made global communication part of daily life in the United States—a few clicks on a computer or a phrase typed into a search engine can bring almost any type of knowledge to the user’s fingertips....
The internet has made global communication part of daily life in the United States—a few clicks on a computer or a phrase typed into a search engine can bring almost any type of knowledge to the user’s fingertips....
The...
11/19/2018
Journal of Clinical Pathways
Editor's Page
10/15/2018
Winston Wong, PharmD, Editor-in-Chief
Innovations in cancer therapy hold remarkable potential to transform treatment of the disease, but it is not enough to innovate new treatments if they are not easily accessible to patients. While the issue of access...
Innovations in cancer therapy hold remarkable potential to transform treatment of the disease, but it is not enough to innovate new treatments if they are not easily accessible to patients. While the issue of access...
...
10/15/2018
Journal of Clinical Pathways
Editor's Page
09/13/2018
Winston Wong, PharmD, Editor-in-Chief
The advancements made in health care, and oncology care specifically, have improved treatment and patient care tremendously, and have the potential to make an even greater impact as care delivery becomes more...
The advancements made in health care, and oncology care specifically, have improved treatment and patient care tremendously, and have the potential to make an even greater impact as care delivery becomes more...
The...
09/13/2018
Journal of Clinical Pathways
Editor's Page
08/22/2018
Winston Wong, PharmD, Editor-in-Chief
As new and exciting advancements in cancer drugs and care are made, updated guidance and regulations must follow. Oncologists and other stakeholders must keep up with the latest rules and regulations in order to...
As new and exciting advancements in cancer drugs and care are made, updated guidance and regulations must follow. Oncologists and other stakeholders must keep up with the latest rules and regulations in order to...
As new...
08/22/2018
Journal of Clinical Pathways
Viewpoint
08/22/2018
Winston Wong, PharmD, Editor-in-Chief
The Centers for Medicare and Medicaid Services (CMS) just announced their reimbursement level for the new chimeric antigen receptor T-cell (CAR-T) products. While it is in line with their standard reimbursement...
The Centers for Medicare and Medicaid Services (CMS) just announced their reimbursement level for the new chimeric antigen receptor T-cell (CAR-T) products. While it is in line with their standard reimbursement...
The...
08/22/2018
Journal of Clinical Pathways
Editor's Page
06/14/2018
Winston Wong, PharmD, Editor-in-Chief
The ongoing journey toward value-based care has led to innovations in care delivery and reimbursement. Many new concepts and strategies have evolved from concept to reality. We now have gathered enough long-term data...
The ongoing journey toward value-based care has led to innovations in care delivery and reimbursement. Many new concepts and strategies have evolved from concept to reality. We now have gathered enough long-term data...
The...
06/14/2018
Journal of Clinical Pathways
Editor's Page
05/21/2018
Winston Wong, PharmD, Editor-in-Chief
Acute myelogenous leukemia (AML) is a rapid progressing malignancy of the myeloid progenitor cells, characterized by an uncontrolled proliferation of primitive blast cells replacing normal bone marrow cells. It is...
Acute myelogenous leukemia (AML) is a rapid progressing malignancy of the myeloid progenitor cells, characterized by an uncontrolled proliferation of primitive blast cells replacing normal bone marrow cells. It is...
Acute...
05/21/2018
Journal of Clinical Pathways
Editor's Page
05/15/2018
Winston Wong, PharmD, Editor-in-Chief
Making the transition from fee-for-service reimbursement to value-based models of care and payments will be slow and difficult. As the initial concepts behind value-based reimbursement and care delivery models...
Making the transition from fee-for-service reimbursement to value-based models of care and payments will be slow and difficult. As the initial concepts behind value-based reimbursement and care delivery models...
Making...
05/15/2018
Journal of Clinical Pathways
Viewpoint
04/17/2018
Winston Wong, PharmD, Editor-in-Chief
The ability to rewire human immune systems to fight cancer is certainly an exciting prospect. With the first 2 chimeric antigen receptor T-cell (CAR-T) therapies approved and over 200 more in clinical trials,...
The ability to rewire human immune systems to fight cancer is certainly an exciting prospect. With the first 2 chimeric antigen receptor T-cell (CAR-T) therapies approved and over 200 more in clinical trials,...
The...
04/17/2018
Journal of Clinical Pathways
Editor's Page
04/17/2018
Winston Wong, PharmD, Editor-in-Chief
It is an exciting time in oncology care as innovative cellular and gene therapies come to market, with many more to come in the near future. While the promise of these therapies is certainly cause for enthusiasm,...
It is an exciting time in oncology care as innovative cellular and gene therapies come to market, with many more to come in the near future. While the promise of these therapies is certainly cause for enthusiasm,...
It is...
04/17/2018
Journal of Clinical Pathways